Saroja Pharma Industries India (SAROJA)₹40.00+3.09%Specialty Chemicals
Saroja Pharma Industries India is compared with the 10 closest in size in Specialty Chemicals (135 companies in the industry). It has a P/E of 10.0 against a peer median of 18.7, and ROCE of 13.0% against a peer median of 8.0%, and latest-quarter sales growth of −10.3% against a peer median of 5.8%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Specialty Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bhatia Colour Chem | 33 | 7.7 | 8.0 | 4.5 | 0.02 | 0.0 | 155 | 4 | 25.8 | −50.3 | vs SAROJA |
| Dynamic Industries | 33 | 17.9 | 5.9 | 3.7 | 0.28 | 0.9 | 72 | 2 | −8.6 | −7.4 | vs SAROJA |
| Seya Industries | 31 | — | −0.3 | −0.4 | 0.94 | 0.0 | 0 | −3 | — | — | vs SAROJA |
| Yug Decor | 31 | 481.5 | 5.8 | 0.6 | 0.78 | 0.0 | 39 | 0 | 10.1 | −76.5 | vs SAROJA |
| Crestchem | 30 | 11.1 | 37.9 | 27.4 | 0.00 | 1.5 | 29 | 3 | — | — | vs SAROJA |
| Machhar Industries | 25 | 31.5 | 8.4 | 6.2 | 0.25 | 0.0 | 16 | 1 | 28.6 | 233.3 | vs SAROJA |
| Daikaffil Chemicals India | 24 | — | 12.5 | −32.6 | 0.00 | 0.0 | 13 | −2 | — | — | vs SAROJA |
| Organic Coatings | 24 | — | −24.1 | −197.0 | 508.02 | 0.0 | 28 | −3 | 51.9 | — | vs SAROJA |
| Saroja Pharma Industries India | 16 | 10.0 | 13.0 | 9.8 | 0.84 | 0.0 | 71 | 2 | −10.3 | 49.3 | — |
| AMS Polymers | 15 | 19.5 | 10.0 | 14.0 | 2.39 | 0.0 | 110 | 1 | 1.4 | −38.9 | vs SAROJA |
| C J Gelatine Products | 13 | 67.1 | 6.6 | 5.2 | 6.09 | 0.0 | 42 | 0 | −0.3 | 300.0 | vs SAROJA |
| Peer median | 25 | 18.7 | 8.0 | 4.5 | 0.78 | 0.0 | 39 | 1 | 5.8 | −7.4 |
Listed companies closest to Saroja Pharma Industries India in Specialty Chemicals include Bhatia Colour Chem, Dynamic Industries, Seya Industries, Yug Decor, Crestchem, Machhar Industries, Daikaffil Chemicals India, Organic Coatings.
Bhatia Colour Chem, with a market cap of ₹32.69 Cr.
Saroja Pharma Industries India trades at a P/E of 10.0; the median of its peer set is 18.7. A P/E above or below the median is a description, not a judgement on value.
Saroja Pharma Industries India's return on capital employed is 13.0%, above the peer median of 8.0%.